The present invention provides an antagonist for endothelin which is considered to have a relation to hypertension, Buerger is disease, asthma, eyegrounds diseases, and the like. Said endothelin antagonist contains 15-keto-prostaglandin E compounds, especially 13,14-dihydro-15-keto-16-mono or dihalo-prostaglandins.